Cogent Biosciences, Inc. COGT Convertible Preferred Stock Converted to Other Securities
Convertible Preferred Stock Converted to Other Securities at other companies
Other financials
Where this comes from
Reported directly by Cogent Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ConvertiblePreferredStockConvertedToOtherSecurities.
The official record: Cogent Biosciences, Inc.’s 10-Q, filed May 7, 2024, on SEC EDGAR. View the filing →
Ask your AI about Cogent Biosciences, Inc.'s convertible preferred stock converted to other securities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cogent Biosciences, Inc.'s convertible preferred stock converted to other securities?
- Cogent Biosciences, Inc. (COGT) reported convertible preferred stock converted to other securities of $0 in Q1 2024.
- How has Cogent Biosciences, Inc.'s convertible preferred stock converted to other securities changed year-over-year?
- Cogent Biosciences, Inc.'s convertible preferred stock converted to other securities decreased by 100.0% year-over-year, from $3.52M to $0.